CaroGen Company

CaroGen develops vaccine candidates targeting hepatitis B and C, and other viral agents.

Last Funding Type: Grant
Funding Status: Seed
Headquarters: Hamden, Connecticut, United States
Founded Date: 2012-01-01
Last Funding Date: 2019-03-27
Total Funding: 1550000
Employee Number: 1-10
Estimated Revenue: Less than $1M
Investors Number: 2
Industry: Viral Vectors